GenomeScan

Plesmanlaan 1d 2333 BB Leiden

As a leading Dutch Next Generation Sequencing (NGS) service provider, GenomeScan develops and provides customizable NGS solutions.

We support scientific community of pharmaceutical industry, biotechnological and agricultural companies, healthcare providers and academic institutions, that have an impact on Healthcare and Quality of Life. To assist you with your mission, we leverage innovative NGS technologies to advance solutions from basic research through preclinical stage to every-day clinical practice, paving the way towards personalized medicine. We provide tailored, end-to-end solutions. Our experienced team guides you along every step: from designing your experimental setup, through sample preparation and full stack reporting, to interpretation of your data with a turnaround time that fits your needs.

GenomeScan operates under ISO/IEC 17025 [L518], ISO 15189 [M308] accreditation to offer customers absolute confidence and trust.

People
Our passionate team consists of scientists and technicians with diverse scientific backgrounds. You can consider them as an extension of your own team with a commitment to provide you with excellent, robust, and fast NGS services with matched bioinformatics solutions.

Quality
We deem quality of a paramount importance, and we fully embrace it by operating under ISO/IEC 17025 and ISO 15189 accreditation. Your personal data and privacy are secured via data management system that guarantees the protection in compliance with (inter)national directives.

Innovation
Our well-established contacts with technology providers, our collaborations with academic researchers, and out participation in numerous scientific consortia spark our innovation to grant you access to the most advanced sequencing methodologies and solutions.

Experience
With a track record of nearly two decades in genetic services and strong support and shareholding of large Academic Medical Centers, we are a partner you can rely on. Whether it involves batched or single-sample processing, prospective or retrospective clinical cohorts, archive samples, biosafety testing material, plant, or microbiome samples, we will deliver.